Category:
Active Pharmaceutical Ingredients
CAS NO:
923032-37-5
Standard:
In-house Standards,
Oncology Pancreatic Cancer
Refametinib is a potent, oral MEK1/2 inhibitor developed for oncology. Its core synthesis involves advanced organic coupling to ensure high purity. Molecular Formula: C24H25N7O3; CAS No.: 1268069-48-2.
Restricted to clinical trials and GMP manufacturing only. Store under inert atmosphere at -20°C. Handle with PPE due to potential mutagenicity and strict regulatory controls on investigational new drugs.